Detection of Factor V Leiden from a drop of blood by PCR-SSCP

Thrombosis and Haemostasis

Volumn 76, Issue 5, 1996, Pages 735-737

  Corral, Javier ^a   Iniesta, Juan A ^a   González Conejero, Rocio ^a   Vicente, Vicente ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCREENING TEST; SINGLE STRAND CONFORMATION POLYMORPHISM; VEIN THROMBOSIS;

EID: 0029911293     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650652     Document Type: Article

References (23)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
2. Bloemenkamp KWM, Rosendaal FR, Heimerhorst FM, Büller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-6.
3. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 324: 1503-6.
4. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-21.
5. Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-22.
6. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
7. Dahlbäck B. Resistance to activated protein C, the Arg 506 to Gln in the factor V gene, and venous thrombosis. Functional test and DNA-based assays, pros and cons. Thromb Haemost 1995; 73: 739-42.
8. Ehrenforth S, Radtke KP, Scharrer I. Acquired activated protein C-resistance in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 793-810.
9. Leroy-Matheron C, Levent M, Pignon J-M, Mendoca C, Gouault-Heilmann M. The 1691 G - A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemost 1996; 75: 4-10.
10. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsman PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
11. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg506 - Gln mutation. Blood Coagulation and Fibrinol 1995; 6: 245-8.
12. van de Locht LTF, Kuypers AWHM, Verbruggen BW, Linssen PCM, Novakova IRO, Mensink EJBM. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemost 1995; 74: 1276-9.
13. Rabes JP, Trossaert M, Conard J, Giraudet P, Boileau C. Single point mutation at Arg (506) of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis. Thromb Haemost 1995; 74: 1379.
14. Kirschbaum NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost 1995; 74: 874-8.
15. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
16. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7.
17. Ohhara M, Kurosu Y, Esumi M. Direct PCR of whole blood and hair shafts by microwave treatment. Biotechniques 1994; 17: 727-8.
18. Panaccio M, Lew AM. PCR based diagnosis in the presence of 8% (v/v) blood. Nucleic Acids Res 1991; 19: 1151.
19. Panaccio M, Georgesz M, Lew AM. FoLT PCR: a simple PCR protocol for amplifying DNA directly from whole blood. Biotechniques, 1993; 14: 238-43.
20. Hayasi K. PCR-SSCP: a method for detection of mutations. GATA 1992; 9: 73-9.
21. Ainsworth PJ, Surh LC, Coulter-Mackie MB. Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acid Res 1991; 19: 405-6.
22. Dockhorn-Dworniczak B, Dworniczak B, Brommelkamp L, Bulles J, Horst J, Bocker WW. Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res 1991; 19: 2500.
23. Mohabeer AJ, Hiti AL, Martin WJ. Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia "Phastsystem". Nucleic Acid Res 1991; 19: 3154.